Skip to main content

Together we are beating cancer

Donate now

Health & Medicine

Find out more about the latest cancer treatments, clinical trials, cancer prevention and health policy
Showing 12 out of 3432 results
Cigarette in ashtray

Researchers also found the number of high-risk drinkers rose by 40%, with over 4.5 million adults classed as 'high-risk drinkers' during the first lockdown. Researchers also found the number of high-risk drinkers rose by 40%, with over 4.5 million adults classed as 'high-risk drinkers' during the first lockdown.

by Cancer Research UK | News | 25 August 2021

25 August 2021

The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year. The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year.

by Cancer Research UK | News | 24 August 2021

24 August 2021

NHS building in Cheshire

Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role. Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role.

by Michelle Mitchell | Opinion | 19 August 2021

19 August 2021

  • Science & Technology
  • Health & Medicine

Innovative cancer spinouts: 3 new projects get green light

The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours. The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.

by Cancer Research UK | News | 13 August 2021

13 August 2021

3D rendering of oesophageal cancer

The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer. The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer.

by Harry Jenkins | News | 11 August 2021

11 August 2021

  • Science & Technology
  • Health & Medicine
  • For Researchers

Why people and culture matter in research

We bring you a summary of the government’s recent R&D People & Culture Strategy and what it could mean for cancer researchers We bring you a summary of the government’s recent R&D People & Culture Strategy and what it could mean for cancer researchers

by Cancer Research UK | Research Feature | 10 August 2021

10 August 2021

Clinician holds hand of patient on hospital bed.

Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK. Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK.

by Cancer Research UK | News | 5 August 2021

5 August 2021

Lung cancer CT scan

1 in 2 people in the UK will be diagnosed with some form of cancer during their lifetime. We’ve estimated the impact different types of activity could make to ambitions to diagnose cancer earlier. 1 in 2 people in the UK will be diagnosed with some form of cancer during their lifetime. We’ve estimated the impact different types of activity could make to ambitions to diagnose cancer earlier.

by Hope Walters | Analysis | 27 July 2021

27 July 2021

A transgender woman in a hospital gown speaking to her doctor, a transgender man, in an exam room.

LGBTQIA+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQIA+ people. LGBTQIA+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQIA+ people.

by Harry Jenkins | Analysis | 26 July 2021

26 July 2021